NASDAQ:INBS Intelligent Bio Solutions Q1 2025 Earnings Report $1.77 -0.03 (-1.67%) Closing price 09/23/2026 04:00 PM EasternExtended Trading$1.84 +0.06 (+3.67%) As of 04:58 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Intelligent Bio Solutions EPS ResultsActual EPS-$7.00Consensus EPS -$5.30Beat/MissMissed by -$1.70One Year Ago EPSN/AIntelligent Bio Solutions Revenue ResultsActual Revenue$872.29 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AIntelligent Bio Solutions Announcement DetailsQuarterQ1 2025Date11/7/2024TimeBefore Market OpensConference Call DateThursday, November 7, 2024Conference Call Time7:00AM ETUpcoming EarningsIntelligent Bio Solutions' Q1 2027 earnings is estimated for Wednesday, November 11, 2026, based on past reporting schedules, with a conference call scheduled on Monday, November 9, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesPress Release (8-K)Quarterly Report (10-Q)Earnings HistoryCompany ProfilePowered by Earnings DocumentsPress Release(8-K)Quarterly report(10-Q) Intelligent Bio Solutions Earnings HeadlinesIntelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ETSeptember 10, 2026 | globenewswire.comIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | finanznachrichten.deElon gets it. Do you?Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.September 24 at 1:00 AM | Porter & Company (Ad)Intelligent Bio Solutions Seeks FDA Clearance For Fingerprint-Based Drug Screening SystemSeptember 9, 2026 | rttnews.comIntelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market ClearanceSeptember 9, 2026 | globenewswire.comIntelligent Bio Solutions Secures $5M Funding As Drug Screening System Nears FDA FilingSeptember 1, 2026 | rttnews.comSee More Intelligent Bio Solutions Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Intelligent Bio Solutions? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intelligent Bio Solutions and other key companies, straight to your email. Email Address About Intelligent Bio SolutionsIntelligent Bio Solutions (NASDAQ:INBS) is a life sciences company focused on non-invasive diagnostic and drug-screening technologies. Its primary product is the Intelligent Fingerprinting Drug Screening System, which analyzes sweat collected from a fingerprint to identify drug metabolites. The system is designed to provide rapid, portable testing without blood or urine collection. It is intended for use by organizations such as employers, law enforcement agencies, drug-treatment providers, and other institutions that require convenient drug screening and monitoring. The company’s technology originated with Intelligent Fingerprinting, a United Kingdom-based developer that was acquired by Intelligent Bio Solutions. Intelligent Bio Solutions, formerly known as GBS Inc., has pursued commercialization of the fingerprint-based testing platform in markets including the United States, the United Kingdom, Australia, and other international regions.View Intelligent Bio Solutions ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Energy Transfer Taps the AI Power BoomFull Throttle: Kratos and GE Fire Up a Next-Gen Defense EngineSandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?Thor Industries Is Boring—And That May Be Its Biggest AdvantageAutoZone Shifts Gears, On Track to Reverse Course and Price RecoveryMeta’s Muse Highlights Arm’s Growing Role in AI InfrastructureOld Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
